Literature DB >> 6326893

Abnormal expansions of polyclonal large to small size granular lymphocytes: reactive or neoplastic process?

G Semenzato, G Pizzolo, A Ranucci, C Agostini, M Chilosi, I Quinti, G De Sanctis, B Vercelli, F Pandolfi.   

Abstract

Morphological, immunologic, and functional properties of peripheral blood cells from two patients with chronic proliferations of granular lymphocytes are described. Cells from both patients showed a heterogeneous pattern from both a morphological and immunologic standpoint, indicating a polyclonal, rather than a monoclonal, expansion of these cells. In fact, both large and small-to-medium-sized granular lymphocytes were observed, and different percentages of positivity were found in the analysis with a large panel of monoclonal antibodies. Serologic and histologic features support the hypothesis that this lymphocytosis could be secondary to bacterial or viral infections rather than a primary event, suggesting that these patients may have chronic reactive immunoregulatory disorders.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6326893

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  10 in total

1.  Immunophenotypic analysis of the TCR-Vbeta repertoire in 98 persistent expansions of CD3(+)/TCR-alphabeta(+) large granular lymphocytes: utility in assessing clonality and insights into the pathogenesis of the disease.

Authors:  M Lima; J Almeida; A H Santos; M dos Anjos Teixeira; M C Alguero; M L Queirós; A Balanzategui; B Justiça; M Gonzalez; J F San Miguel; A Orfão
Journal:  Am J Pathol       Date:  2001-11       Impact factor: 4.307

2.  Lymphoproliferative disease of granular lymphocytes in a patient with concomitant hepatitis B virus infection of CD4 lymphocytes.

Authors:  C Agostini; R Zambello; P Pontisso; A Alberti; L Trentin; F Siviero; R Foà; F Pandolfi; G Semenzato
Journal:  J Clin Immunol       Date:  1989-09       Impact factor: 8.317

Review 3.  Abnormal expansions of granular lymphocytes: reactive lymphocytosis or chronic leukemia? Case report and literature review.

Authors:  G Gastl; H Rumpold; D Kraft; C Gattringer; G Schuler; R Margreiter; F Schmalzl; C Huber
Journal:  Blut       Date:  1986-02

Review 4.  All that glitters is not LGL Leukemia.

Authors:  Gianpietro Semenzato; Antonella Teramo; Giulia Calabretto; Vanessa Rebecca Gasparini; Renato Zambello
Journal:  Leukemia       Date:  2022-09-15       Impact factor: 12.883

5.  Predominant activation and expansion of V gamma 9-bearing gamma delta T cells in vivo as well as in vitro in Salmonella infection.

Authors:  T Hara; Y Mizuno; K Takaki; H Takada; H Akeda; T Aoki; M Nagata; K Ueda; G Matsuzaki; Y Yoshikai
Journal:  J Clin Invest       Date:  1992-07       Impact factor: 14.808

6.  T cells in patients with chronic T gamma lymphocytosis: morphology, cytochemistry, ultrastructure and immunological characteristics.

Authors:  J W Smit; N R Blom; M J van Luyn; F Miedema; C J Melief; M R Halie
Journal:  Blut       Date:  1985-08

7.  Polyclonal proliferation of activated suppressor/cytotoxic T cells with transient depression of natural killer cell function in acute infectious mononucleosis.

Authors:  M L Williams; T P Loughran; P G Kidd; G A Starkebaum
Journal:  Clin Exp Immunol       Date:  1989-07       Impact factor: 4.330

8.  Cytotoxic in vitro function in the lymphoproliferative disease of granular lymphocytes.

Authors:  R Zambello; T Chisesi; C Agostini; L Trentin; M Masciarelli; G Gasparotto; M Vespignani; G Casorati; R Foa; G Semenzato
Journal:  Clin Exp Immunol       Date:  1987-10       Impact factor: 4.330

9.  T cell receptor beta chain gene rearrangements in lymphoproliferative disorders of large granular lymphocytes/natural killer cells.

Authors:  A Rambaldi; P G Pelicci; P Allavena; D M Knowles; S Rossini; R Bassan; T Barbui; R Dalla-Favera; A Mantovani
Journal:  J Exp Med       Date:  1985-12-01       Impact factor: 14.307

Review 10.  Biology of natural killer cells.

Authors:  G Trinchieri
Journal:  Adv Immunol       Date:  1989       Impact factor: 3.543

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.